Envestnet Asset Management Inc Amphastar Pharmaceuticals, Inc. Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q3 2024
A detailed history of Envestnet Asset Management Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 34,666 shares of AMPH stock, worth $1.55 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,666
Previous 25,360
36.7%
Holding current value
$1.55 Million
Previous $1.01 Million
65.88%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMPH
# of Institutions
286Shares Held
35.1MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$265 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$121 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$95.2 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$86.9 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$72 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.19B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...